GB1483165A - Pharmaceutical compositions and a process for the preparation thereof - Google Patents
Pharmaceutical compositions and a process for the preparation thereofInfo
- Publication number
- GB1483165A GB1483165A GB4978875A GB4978875A GB1483165A GB 1483165 A GB1483165 A GB 1483165A GB 4978875 A GB4978875 A GB 4978875A GB 4978875 A GB4978875 A GB 4978875A GB 1483165 A GB1483165 A GB 1483165A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- pharmaceutical compositions
- dec
- weight
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
1483165 Anti-inflammatory compositions RICHTER GEDEON VEGYESZETI GYAR RT 4 Dec 1975 [12 Dec 1974] 49788/75 Heading A5B Pharmaceutical compositions having antiinflammatory activity contain as an anti-inflammatory agent indomethacin, niflumic acid, phenylbutazone or acetylsalicylic acid or a pharmaceutically acceptable salt of any of these compounds, and 0.2 to 50 parts by weight of salicylic acid or an alkali metal (e.g. sodium or lithium) salicylate for one part by weight of the anti-inflammatory agent. The compositions may be administered orally, rectally or parenterally in the form of tablets, sugar- or filmcoated tablets, capsules, suppositories and injectable solutions which may also contain a local anaesthetic agent e.g. lidocaine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HURI000556 HU170329B (en) | 1974-12-12 | 1974-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1483165A true GB1483165A (en) | 1977-08-17 |
Family
ID=11000967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4978875A Expired GB1483165A (en) | 1974-12-12 | 1975-12-04 | Pharmaceutical compositions and a process for the preparation thereof |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5182715A (en) |
AT (1) | AT342191B (en) |
BE (1) | BE836400A (en) |
CY (1) | CY1098A (en) |
DD (1) | DD121711A5 (en) |
DE (1) | DE2554902C3 (en) |
FR (1) | FR2293938A1 (en) |
GB (1) | GB1483165A (en) |
GT (1) | GT198066593A (en) |
HK (1) | HK70580A (en) |
HU (1) | HU170329B (en) |
KE (1) | KE3101A (en) |
MY (1) | MY8100249A (en) |
NL (1) | NL7514554A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228161A (en) | 1979-03-28 | 1980-10-14 | Merck & Co., Inc. | Anti-inflammatory combination having reduced ulcerogenicity |
EP0031561A2 (en) * | 1979-12-20 | 1981-07-08 | Merck & Co. Inc. | A rectally administered suppository comprising a drug and an adjuvant |
EP0036145A1 (en) * | 1980-03-07 | 1981-09-23 | INTERx RESEARCH CORPORATION | An orally administered drug form comprising a polar bioactive agent and an adjuvant |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE863935A (en) * | 1977-02-26 | 1978-08-14 | Basf Ag | USE OF 1,2-PROPYLENE-GLYCOL-1-N-PROPYL ETHER AS A SOLVENT FOR PHARMACEUTICAL PREPARATIONS |
SE8302689L (en) * | 1982-05-14 | 1983-11-15 | Richter Gedeon Vegyeszet | PHARMACEUTICAL COMPOSITIONS CONTAINING MULTIPLE ACTIVE INGREDIENTS |
MX2013008995A (en) * | 2013-08-02 | 2014-03-24 | Raam De Sahuayo S A De C V Lab | Pharmaceutical composition for treating pain. |
-
1974
- 1974-12-12 HU HURI000556 patent/HU170329B/hu not_active IP Right Cessation
-
1975
- 1975-12-03 AT AT919575A patent/AT342191B/en not_active IP Right Cessation
- 1975-12-04 GB GB4978875A patent/GB1483165A/en not_active Expired
- 1975-12-04 CY CY109875A patent/CY1098A/en unknown
- 1975-12-05 DE DE19752554902 patent/DE2554902C3/en not_active Expired
- 1975-12-08 BE BE162549A patent/BE836400A/en not_active IP Right Cessation
- 1975-12-11 DD DD19005275A patent/DD121711A5/xx unknown
- 1975-12-11 JP JP14789575A patent/JPS5182715A/en active Pending
- 1975-12-11 FR FR7537976A patent/FR2293938A1/en active Granted
- 1975-12-12 NL NL7514554A patent/NL7514554A/en active Search and Examination
-
1980
- 1980-11-19 KE KE310180A patent/KE3101A/en unknown
- 1980-12-01 GT GT198066593A patent/GT198066593A/en unknown
- 1980-12-18 HK HK70580A patent/HK70580A/en unknown
-
1981
- 1981-12-30 MY MY8100249A patent/MY8100249A/en unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228161A (en) | 1979-03-28 | 1980-10-14 | Merck & Co., Inc. | Anti-inflammatory combination having reduced ulcerogenicity |
EP0031561A2 (en) * | 1979-12-20 | 1981-07-08 | Merck & Co. Inc. | A rectally administered suppository comprising a drug and an adjuvant |
EP0031561A3 (en) * | 1979-12-20 | 1982-08-11 | Merck & Co. Inc. | A rectally administered drug form comprising a drug and an adjuvant |
DK156121B (en) * | 1979-12-20 | 1989-06-26 | Merck & Co Inc | PROCEDURE FOR PREPARING A RECTAL ADMINISTRATIVE SUPPLY WITH A ADJUVANCE |
EP0036145A1 (en) * | 1980-03-07 | 1981-09-23 | INTERx RESEARCH CORPORATION | An orally administered drug form comprising a polar bioactive agent and an adjuvant |
Also Published As
Publication number | Publication date |
---|---|
CY1098A (en) | 1981-04-17 |
AT342191B (en) | 1978-03-28 |
BE836400A (en) | 1976-04-01 |
HU170329B (en) | 1977-05-28 |
GT198066593A (en) | 1982-05-25 |
DE2554902C3 (en) | 1978-12-14 |
FR2293938A1 (en) | 1976-07-09 |
JPS5182715A (en) | 1976-07-20 |
MY8100249A (en) | 1981-12-31 |
HK70580A (en) | 1980-12-24 |
ATA919575A (en) | 1977-07-15 |
DE2554902A1 (en) | 1976-06-16 |
FR2293938B1 (en) | 1979-06-29 |
DD121711A5 (en) | 1976-08-20 |
NL7514554A (en) | 1976-06-15 |
KE3101A (en) | 1981-02-13 |
DE2554902B2 (en) | 1978-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1274271A (en) | Improvements in or relating to propionic acid derivatives | |
GB1178034A (en) | Hydroxy-Cyclohexylamines | |
GB1483165A (en) | Pharmaceutical compositions and a process for the preparation thereof | |
GB1192701A (en) | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same | |
GB1015787A (en) | Tris-(p-methoxyphenyl)ethylene derivatives | |
GB1164510A (en) | Novel Isoxazole Derivatives, the preparation thereof, and Compositions containing the same | |
GB1256723A (en) | ||
GB1153640A (en) | A Carnitin Salt | |
GB1252286A (en) | ||
GB1131164A (en) | Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them | |
GB1204172A (en) | Pharmaceutical compositions | |
GB1518333A (en) | Pharmaceutical compositions containing a ypsilon-resorcylic acid derivative | |
GB1499720A (en) | Method of preventing thrombosis | |
GB879425A (en) | Choleretic, non-cholagogic agents containing alpha-(hydroxy-phenylcyclohexyl) butyric acids | |
IE34139B1 (en) | 4-phenyl-butric acid derivatives | |
GB1388856A (en) | Fibrinolytic activators comprising derivatives of phenyl benzoate | |
GB1352392A (en) | Phenylisopropylamine derivatives | |
GB1268523A (en) | Dihydrofuran derivatives, the preparation thereof, and compositions containing the same | |
GB1301857A (en) | ||
GB909688A (en) | 5-substituted-2,4-disulfamyl (halo) acylanilides | |
GB1158954A (en) | N-(4-Carboxy-Phenyl)-Anthranilic Acid, derivatives thereof and a process for their preparation | |
ES342394A1 (en) | Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same | |
GB1159271A (en) | 1,5-Disubstituted Barbituric Acid Derivatives and process for the manufacture thereof | |
GB1287433A (en) | Pharmaceutical compositions | |
GB1188109A (en) | Improvements in or relating to a novel Bis-(p-Chlorophenoxy)-Acetic Acid Ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |